Tablet formulation of 2-fluoro-n-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12208101
APP PUB NO 20220249498A1
SERIAL NO

17644473

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is related to tablets comprising of 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide, processes for the production thereof, and uses in the treatment of certain cancers.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS AGBASEL SUI BASEL BASEL-STADT

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Goncalves, Elisabete Basel, CH 11 13
Tauchmann, Christin Bad Säckingen, DE 4 7
Vippagunta, Sudha Morris Plains, US 10 26
Yen, Shau-Fong Basel, CH 19 72
Zong, Zhixin Franklin Park, US 8 79

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jul 28, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 28, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 28, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00